The fusion product of human MLL and murine Af4 (MLL–Af4) initiates pro-B-ALL that recapitulates the human pathology but causes AML when the cells were culture in myeloid-promoting conditions (52). The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.